The U.S. Food and Drug Administration (FDA) recently published the guidance, Unique Device Identification: Policy Regarding Compliance Dates for Class I and Unclassified Devices Immediately in Effect Guidance for Industry and Food and Drug Administration Staff. The guidance formally outlines when the FDA intends to enforce UDI labeling, GUDID data submissions, standard date format, and direct marking requirements for Class I and unclassified devices that are not implantable, life-supporting, or life-sustaining.

The guidance reflects both the extension provided in the Letter to Device Labelers on UDI Compliance Dates for Class I and Unclassified Devices – June 2, 2017 as well as the three-year grace period for products manufactured and labeled prior to the compliance date published in the final rule. See the below table for details on when the FDA intends to enforce the requirements:

Our knowledgeable professionals can design a program to meet your specific needs - whether it be to demonstrate quality and safety control, identify which product offers the best value, which product your customers prefer, or if the product meets your quality requirements.

For over 35 years, Bureau Veritas has worked successfully with top retailers and manufacturers around the world to help them better manage risk and regulatory compliance. If you have any questions, please contact your customer service representative or email: cps.info@us.bureauveritas.com.